A detailed history of Smartleaf Asset Management LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 944 shares of FOLD stock, worth $9,119. This represents 0.0% of its overall portfolio holdings.

Number of Shares
944
Previous 900 4.89%
Holding current value
$9,119
Previous $8.92 Million 13.35%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$9.55 - $12.09 $420 - $531
44 Added 4.89%
944 $10.1 Million
Q2 2024

Aug 13, 2024

BUY
$9.04 - $11.75 $8,135 - $10,575
900 New
900 $8.92 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.71B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.